New Osteoporosis Medication Approved By FDA

The US Food and Drug Administration(FDA) recently approved the first drug in a new class of osteoporosis-fighting medications known as RANKL, or RANK ligand inhibitors. These medications work decrease bone loss in a way that is different from other osteoporosis medications (such as Fosamax, Boniva, etc.)

The newly approved drug, denosumab (Prolia), is an injectable medication derived from a synthetic antibody. It is approved by the FDA for treating postmenopausal women with osteoporosis and other patients who have failed or couldn't tolerate other medications.

To learn more, call 260-9322.

How We're Different

Many doctors approach patients with back pain by using narcotics or recommending surgery. By the time a patient sees a pain specialist, they are often going to get 3 steroid injections and then sent for a variety of tests leading up to spinal fusion.

At our clinic, we try to help patients avoid surgery. Here are some key ways that we are different:

* Advanced imaging studies, such as MRI, are critical to selecting the correct treatment plan for patients with pain. Dr. Webb is the only pain physician in Tulsa who is board-certified to read imaging studies.
* You get seen in days, not weeks.
* Pain relieving procedure done within days, not weeks.
* Leader in minimally invasive alternatives to surgery for patients with pain.
* Comprehensive pain intervention from epidural steroid injections to minimally invasive decompression.
* Focus on osteoporosis, spine fracture fixation with advanced level of training and specializing in complex cases.